KH
Kersi Homi Tangri
About Kersi Homi Tangri
Data last updated:
Kersi Homi Tangri is a Director at Avesta Pharma Private Limited (since 2009), Whole-Time Director at Biesterfeld Hildose Speciality Chemicals Private Limited (since 2023) and Director at Accusynth Speciality Chemicals Private Limited (since 2006), and holds 3 more current directorships. The companies operate in Manufacturing, Chemicals and Materials and Household Services. The 4 current companies with reported revenue have a combined latest revenue of ₹281 Cr; the largest is Avesta Pharma Private Limited at ₹202 Cr (FY 2025). Earlier, Kersi Homi Tangri was a Director at Dyna Glycols Private Limited (2006–2018) and Director at Hildose Pharma Private Limited (2012–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 May 2009 | 2009 | ₹202 Cr (FY 2025) | Active | |
| Whole-Time Director | 17 Nov 2023 | 2023 | ₹53.44 Cr (FY 2025) | Active | |
| Director | 27 Jul 2006 | 1979 | ₹24.90 Cr (FY 2020) | Active | |
| Director | 05 Aug 2010 | 1978 | ₹22.8 Lakh (FY 2025) | Active | |
| Designated Partner | 12 Feb 2020 | 2020 | Active | ||
| Director | 10 Jun 2008 | 2008 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2006 | 2006 | ₹303 Cr (FY 2024) | Active | |
| Director | 24 Dec 2012 | 2012 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kersi Homi Tangri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kersi Homi Tangri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kersi Homi Tangri
Kersi Homi Tangri currently holds 6 directorships: Avesta Pharma Private Limited (Director, since 25 May 2009, revenue ₹202 Cr (FY 2025)); Biesterfeld Hildose Speciality Chemicals Private Limited (Whole-Time Director, since 17 Nov 2023, revenue ₹53.44 Cr (FY 2025)); Accusynth Speciality Chemicals Private Limited (Director, since 27 Jul 2006, revenue ₹24.90 Cr (FY 2020)); Firoze Estates Private Limited (Director, since 05 Aug 2010, revenue ₹22.8 Lakh (FY 2025)); Hildose Pharmaspecialities Llp (Designated Partner, since 12 Feb 2020); and 1 more.
Kersi Homi Tangri was first appointed on 27 Jul 2006 as Director at Accusynth Speciality Chemicals Private Limited. The most recent appointment on record is 17 Nov 2023 at Biesterfeld Hildose Speciality Chemicals Private Limited.
The 4 current companies of Kersi Homi Tangri that report revenue have a combined latest revenue of ₹281 Cr: Avesta Pharma Private Limited ₹202 Cr (FY 2025); Biesterfeld Hildose Speciality Chemicals Private Limited ₹53.44 Cr (FY 2025); Accusynth Speciality Chemicals Private Limited ₹24.90 Cr (FY 2020); Firoze Estates Private Limited ₹22.8 Lakh (FY 2025).
Kersi Homi Tangri held 2 earlier board appointments: Dyna Glycols Private Limited (Director, 01 Sep 2006 to 02 Jun 2018); Hildose Pharma Private Limited (Director, 24 Dec 2012 to 11 Feb 2020).
The current boards of Kersi Homi Tangri's companies include Amol Ashok Walke (Avesta Pharma Private Limited), Eric Kersi Tangri (Avesta Pharma Private Limited), Mahesh Hakmichand Doshi (Avesta Pharma Private Limited), Zubin Keki Gandhi (Avesta Pharma Private Limited), Andreas Wilhelm Lekebusch (Biesterfeld Hildose Speciality Chemicals Private Limited), Bettina Heick (Biesterfeld Hildose Speciality Chemicals Private Limited), among others.